In this webinar, Andrea focuses on the importance of ligand binding assays in the bioanalysis of small molecule and complex biologics, and highlights the role of orthogonal assays, such as LC-MS, in complementing ligand binding assay data. She covers preclinical, nonclinical (GLP), and clinical assay development and design, including the creation of immunogenicity assays, and the detection of anti-drug antibodies (ADAs). The webinar also features a case study demonstrating the value of bioanalysis data in developing a therapy for a rare pediatric disease.